Sat.Dec 16, 2023 - Fri.Dec 22, 2023

article thumbnail

How Patient Characteristics, SDOH, Impact CLL, SLL Treatment Backdrop

Drug Topics

Social determinants of health (SDOH), such as financial disparities or lack of insurance, create barriers to accessing breakthrough therapies like BTK inhibitors among patients with CLL and SLL.

Insurance 551
article thumbnail

Trends shaping the pharmaceutical industry in 2024

PharmaVoice

Advancements in cloud and AI technology will transform clinical trial efficiency and engagement.

340
340
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Doxycycline for Treatment of Pneumococcal Infection Could Reduce Clostridioides difficile Infection

Pharmacy Times

Less than 1% of individuals developed Clostridioides difficile infection (CDI), but for those who previously had a CDI the year before, 12% developed a new infection.

160
160
article thumbnail

Health data breaches hit an all-time high in 2023

STAT

Odds are, you’ve gotten at least one of the unnerving letters in your mailbox this year: “We’re writing to inform you of a cybersecurity incident,” it might start. It’s the standard notice many health care organizations are required to provide when your protected health information gets exposed — and in 2023, data leaks, hacks, and mishandling led more of them to be delivered than ever before.

HIPAA 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Saturday Night Live Skit Met With Criticism for Tone-Deaf Take on Sickle Cell Disease

Drug Topics

A Saturday Night Live skit has been met with criticism for its caricatured portrayal of patients with sickle cell disease, especially as the performance cast a dark shadow over the recent breakthrough FDA treatment approvals.

FDA 501
article thumbnail

What are pharma’s next blockbusters?

PharmaVoice

In a shifting market focused on targeted therapeutics, drugs that generate big profits are still a priority.

298
298

More Trending

article thumbnail

U.S. government spent more on health care in 2022 than six countries with universal health care combined

STAT

American taxpayers footed the bill for at least $1.8 trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services. On top of that $1.8 trillion, third-party programs, which are often government-funded, and public health programs accounted for another $600 billion in spendin

Insurance 145
article thumbnail

Assessing B-Cell Maturation Antigen Directed Therapies in Multiple Myeloma Treatment

Drug Topics

Three posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked into the efficacy and safety of the therapies.

502
502
article thumbnail

As ALS research booms, one treatment center finds itself in the spotlight

PharmaVoice

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

264
264
article thumbnail

The Role of Pharmacists in HIV Care Continues to Expand

Pharmacy Times

Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.

153
153
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

STAT

Mary Brown was sipping coffee at home in Ontario, Calif., Sunday morning when a friend sent a video clip that ruined her breakfast. It contained a skit from “Saturday Night Live” the night before about the new gene therapies for sickle cell disease. In it, workers gather for an office white-elephant-style gift exchange. A white employee, played by Kate McKinnon, gives a Black employee with sickle cell, played by Kenan Thompson, enrollment in “Vertex Pharmaceutical and CRISPR

145
145
article thumbnail

Patients Hospitalized with COVID-19, Flu at Increased Risk of Long-Term Health Effects

Drug Topics

Patients hospitalized for either virus had an increased risk of death, hospital readmission, and health problems in multiple organ systems over 18 months of follow-up.

Hospitals 488
article thumbnail

5 noteworthy pharma AI investments in 2023

PharmaVoice

The last year showed how some of the world’s biggest pharma companies are leveraging AI tech.

247
247
article thumbnail

FDA Approves Eplontersen for the Treatment of Adult Patients With ATTRv-PN

Pharmacy Times

The drug is the first medicine to be approved for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis that can be self-administered.

FDA 149
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: In the U.S., scientists see barriers to the development of CAR-T therapies. In Spain, a hospital brews its own

STAT

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy. The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars.

Hospitals 145
article thumbnail

FDA Approves Updated LDL-C Lowering Indication for Esperion’s Nexletol, Nexlizet Tablets

Drug Topics

The federal agency also removed the maximally tolerated qualifier for statin use and the prior cardiovascular morbidity and mortality limitation of use statement.

FDA 307
article thumbnail

This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain

PharmaVoice

Arbor Biotechnologies is looking past CRISPR’s recent regulatory wins and into the next stage of gene editing.

182
182
article thumbnail

Inquiry By Senate Finance Representatives Finds Pharmacies Fail to Protect Privacy of Medical Records

Pharmacy Times

The pharmacies, which include 8 major chains, were revealed to provide prescription records to law enforcement agencies without court orders or warrants.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Inhaled vaccines could stop Covid infections, monkey studies show

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hey there. Today, we get into why Amy Abernethy is leaving Verily, and why the ongoing reckoning with AI doesn’t necessarily need the voice of Google to chime in. Plus, Jason Mast pops in to give an update on Uniqure’s puzzling approach to presenting trial results.

Vaccines 144
article thumbnail

Senate Inquiry Reveals Widespread Flaws in Maintaining Pharmacy Customer Data Privacy

Drug Topics

No major pharmacy chains across the United States require a warrant to release sensitive prescription data, including data regarding birth control or mental health conditions, with law enforcement agencies.

281
281
article thumbnail

Rise of the chief investment officer: Why the unique role works for Roivant

PharmaVoice

Dr. Mayukh Sukhatme, president and chief investment officer for Roivant, discusses the long game of partnering and business deals in biopharma.

162
162
article thumbnail

Formulated Toothpaste Could Improve Allergic Reactions to Peanut Allergy

Pharmacy Times

The results found that INT301 met both its primary and secondary endpoints and could be a safe and effective option for individuals that experience food allergies.

149
149
article thumbnail

Here are the worst biopharma CEOs of 2023

STAT

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023 , then Pfizer CEO Albert Bourla is, unfortunately, the worst. My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps , financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis.

144
144
article thumbnail

Harm Reduction Therapeutics Begins Shipping OTC Naloxone Nasal Spray

Drug Topics

The nonprofit pharmaceutical company plans to begin fulfilling orders for RiVive more broadly in early 2023 and will make it available across the US for free of charge or at a low breakeven cost.

article thumbnail

Biopharma’s FTC headache deepens with guideline shifts years in the making

PharmaVoice

Closer scrutiny of pharma deals has made the M&A landscape trickier as a new approach seeks to expand the competitive arena.

147
147
article thumbnail

Study: Neighborhoods With Lower Socioeconomic Status Linked to Lower Adherence Rates for Those With Heart Failure

Pharmacy Times

The results of the study show the importance of considering neighborhood-level disparities to address and improve medication adherence, according to investigators.

149
149
article thumbnail

STAT+: Medical marijuana companies are using pharma’s sales tactics with little of the same scrutiny

STAT

WASHINGTON — Medical marijuana companies sell medicine, just like pharmaceutical companies. But they’re not playing by the same rules — and that’s putting patients at risk. Several of the largest medical marijuana companies, like Trulieve, Curaleaf, and Verano, are advertising their products as treatments not just for muscle aches, but for major medical conditions like cancer and depression, without evidence to back up those claims.

article thumbnail

Korean Patients With IBD Face Higher Risk of C Difficile

Drug Topics

In a trend similar to that observed among Western patients with IBD, Korean patients with IBD have an elevated risk of Clostridioides difficile (C difficile).

247
247
article thumbnail

How to avoid prednisone withdrawal

The Checkup by Singlecare

Millions of people are prescribed prednisone each year for conditions that range from psoriasis and eczema to multiple sclerosis and rheumatoid arthritis. Prednisone belongs to a class of drugs called corticosteroids (also sometimes called glucocorticoids)—steroids that reduce inflammation in the body by replacing cortisol, a hormone produced in the adrenal glands, and slowing down an overactive immune system.

article thumbnail

Researchers Evaluate New Advancements for RSV Management, Treatment

Pharmacy Times

The most recent advances included an approved vaccine that could immunize both the elderly and pregnant women, along with the release of nirsevimab.

article thumbnail

3 issues to watch in global health in 2024

STAT

As we enter the fifth year of this challenging decade, life finally appears to be inching toward normal — a new normal — on the infectious diseases front. Humans and the SARS-CoV-2 virus seem to be making progress toward a detente with each other. Covid is still a major disruptor, a significant cause of illness and death. But the massive disease waves of the early 2020s have calmed down.

143
143
article thumbnail

Anxiety Identified as Most Prevalent Comorbidity in Patients Using Isotretinoin For Acne

Drug Topics

Investigators recommended that isotetinoin be used with extreme caution among patients with a history of mental illness in light of study findings.

247
247
article thumbnail

2024 Outlook: Despite hurdles, stakeholders bullish on VR in behavioral health

Fierce Healthcare

Though often associated with gaming, virtual reality (VR) is a technology rapidly evolving in healthcare. | VR therapy is not a new concept, though it wasn’t until the last few years that the field became prominent. And as technology has improved and gotten more intuitive to use, it has also become less expensive.

141
141